drugset / Trial / NCT00651157

Viral Therapy in Treating Patients With Metastatic Melanoma

NCT00651157

Phase 2 Completed 23 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

This phase II trial is studying the side effects and how well viral therapy works in treating patients with metastatic melanoma. Viral therapy may be able to kill tumor cells without damaging normal cells.

Timeline

Start
2008-04
Primary completion
2011-12
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Pelareorep Other / unclassified 3e+10 unknown Intravenous

Indications